What is this acronym?
Who is this person?
Who should you contact?
True/False
What is....
100

SCTR 

South Carolina Clinical & Translational Research 

100

Manager of Research Operations 

Julia Brenner

100

You are dying to bring something to the holiday party!


Linda! 

100

The PRG has 43 studies 

False we currently have 54 active studies 

100

This form is required by federal regulations for Investigators to disclose certain financial interests to ensure that the design, conduct or reporting of federally-funded projects will not be biased. 

Financial Disclosure 

200

OCR and ORSP

Office of Clinical Research 

Office of Research and Sponsored Programs 

200

Director of Research Administration 

Erica Blender Brown 

200

If you have an issue with your computer, a software program, or 

The Pediatric Helpdesk (which sends a ticket to Lori and Michael)
200

Originality, Attributability, Legibility, Completeness, Availability, and Accuracy are parts of ALCOA+

True! Please continue to do these things :-)

200

This handbook details a study’s conduct and operations describing a study’s organization, operational data definitions, recruitment, screening, enrollment, randomization, follow-up procedures, data collection methods, data flow, case report forms (CRFs), and quality control procedures.

Manual of Operations (MOO)

300

CTA

Clinical Trial Agreement 

300

Vice Chair of Clinical Research, The Charles P. Darby Department of Pediatrics

John M. Costello, MD

300

If you receive an invoice from EPIC research, or if you foresee a charge related to a study? 

Jasmen Allen and peds-grants@musc.edu

300

Clinical Trial Phase 2 is done to determine the safety of an IND.

False! Safety of trials are determined during Phase 1. Phase 2 continues with safety but is to determine safe dosing. 

300

Signing this document provides assurance that a trial will be conducted according to all stipulations of the protocol and to local legal and regulatory requirements and applicable US federal regulations and ICH E6 Good Clinical Practice (GCP) guidelines. 

Protocol Signature Page 

400

ROC

Research Operations and Collaborations 

400

Chair, The Dr. Charles P. Darby, Jr. Department of Pediatrics

Andrew M. Atz, MD

400

If something is broken (door handle, faucet, toilet)....

Linda 

400

A drug is submitted for FDA approval following Phase IV of a clinical trial. 

False

A drug is submitted for FDA approval following Phase III (safety and efficacy) and prior to Phase IV (post approval surveillance) 


400

An agreement between the investigator and the FDA Code of Federal Regulations, when running a trial to study a new drug or agent, that verifies the investigator has the experience and background required to conduct the trial in a way that is ethical and scientifically sound.

1572

500

IATA 

International Air Transport Association

500

Associate Director Research Opportunities and Collaborations

Signe Denmark, MS, CCRP

500

A general question concerning clincard 

clincard@musc.edu

500
When a new protocol has been uploaded to the IRB, the PRA team needs to review the documentation to ensure there are not changes to the billables, designations, and time points. 

True!

500

This is a letter usually obtained by the by the sponsor from the FDA verifying that the IND was submitted and verified by the FDA to be used for research. (It will usually tell if an IND number is required)

IND Letter 

M
e
n
u